Skip to main content
. 2021 Mar 5;7:25. doi: 10.1038/s41523-021-00233-9

Fig. 2. Pathologic node status by type of neoadjuvant therapy and MRI appearance of axillary nodes.

Fig. 2

Appearance of axillary nodes on MRI and subsequent pathologic node status following neoadjuvant chemotherapy or neoadjuvant endocrine therapy. 1Appearance of axillary nodes was determined based on nodal BIRADS features. 2SLNB: sentinel lymph node biopsy. 3ALND: axillary lymph node dissection.